Mediprobe Research Inc Information

Mediprobe Research Inc., and its' sister company, Acclaim Pharma Research Inc., conduct dermatological Phase I-IV clinical research trials. Mediprobe Research Inc. has the in-house capability and expertise to take your Phase II-IV Clinical Trial right from development through to statistical analysis and final report writing. We can design your study, write the protocol, and develop the case report and informed consent forms. Our experienced staff and dedication to detail ensure that IRB, (REB), TPD, FDA and other regulatory approvals are obtained with a minimum of delay. Our experienced data management group routinely organizes and processes data in the preparation of manuscripts and other medical literature. We will conduct your Phase II-IV Clinical Trial in accordance with Good Clinical Practices, as set out by the ICH. We ensure that your trial will meet all applicable regulatory requirements. Acclaim Pharma Research Inc. is a contract research organization (CRO) that specializes in the management of Phase I Trials. Our 52-bed facility, currently under construction, will allow us to comfortably house subjects for extended time periods while we conduct first-in-human studies and pharmacokinetic studies, such as those needed to show bioequivalence between a generic product and the innovative drug. Acclaim Pharma Research Inc. also includes our state-of-the-art research and analytical laboratory, which adds an additional level of support to our impressive clinical trials capabilities.